The Effect and Safety Profile of Thymoglobulin® in Primary Cardiac Transplant Recipients
The Effect and Safety Profile of Thymoglobulin® in Primary Cardiac Transplant Recipients
Enrolling by invitation · NCT03292861 · Registry updated 2026-01-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Effect and Safety Profile of Thymoglobulin® in Primary Cardiac Transplant Recipients | Heart Transplantation | Enrolling by invitation | Phase 2 | 2026-01-14 | NCT03292861 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Cedars-Sinai Medical Center | 161 |
| Genzyme, a Sanofi Company | 22 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cedars-Sinai Medical Center | Los Angeles | United States | 392 |
| Kaiser Permanente Los Angeles Medical Center | Los Angeles | United States | 134 |